DK455286A - Farmaceutisk middel med langsom frigoering og fremgangsmaade til dets fremstilling - Google Patents

Farmaceutisk middel med langsom frigoering og fremgangsmaade til dets fremstilling Download PDF

Info

Publication number: DK455286A
Authority: DK; Denmark
Prior art keywords: tryptophan; pharmaceutical composition; fumaric acid; procedure; preparation
Prior art date: 1985-09-26

Application number

DK455286A

Other languages

English (en)

Other versions

DK166478B1 (da

DK455286D0 (da

Inventor

Yoshimitsu Iida

Shuji Sumida

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-26

Filing date

1986-09-24

Publication date

1987-03-27

1986-09-24 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1986-09-24 Publication of DK455286D0 publication Critical patent/DK455286D0/da

1987-03-27 Publication of DK455286A publication Critical patent/DK455286A/da

1993-06-01 Application granted granted Critical

1993-06-01 Publication of DK166478B1 publication Critical patent/DK166478B1/da

Links

239000008177 pharmaceutical agent Substances 0.000 title 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 6
QIVBCDIJIAJPQS-UHFFFAOYSA-N tryptophan Chemical compound C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 6
239000001530 fumaric acid Substances 0.000 abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 3
239000013543 active substance Substances 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
235000005985 organic acids Nutrition 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000829 suppository Substances 0.000 abstract 1
239000003826 tablet Substances 0.000 abstract 1
-1 troche Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK455286A 1985-09-26 1986-09-24 Farmaceutisk praeparat med langsom frigoering DK166478B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP21327785		1985-09-26
JP21327785		1985-09-26

Publications (3)

Publication Number	Publication Date
DK455286D0 DK455286D0 (da)	1986-09-24
DK455286A true DK455286A (da)	1987-03-27
DK166478B1 DK166478B1 (da)	1993-06-01

Family

ID=16636441

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK455286A DK166478B1 (da)	1985-09-26	1986-09-24	Farmaceutisk praeparat med langsom frigoering
DK108192A DK170110B1 (da)	1985-09-26	1992-08-31	Farmaceutisk præparat med langsom frigivelse og anvendelse af fumarsyre til fremstilling af præpar atet

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK108192A DK170110B1 (da)	1985-09-26	1992-08-31	Farmaceutisk præparat med langsom frigivelse og anvendelse af fumarsyre til fremstilling af præpar atet

Country Status (15)

Country	Link
US (1)	US5188840A (da)
EP (2)	EP0386801B1 (da)
JP (1)	JPH0772142B2 (da)
KR (1)	KR950010145B1 (da)
AT (2)	ATE108647T1 (da)
AU (1)	AU587281B2 (da)
CA (1)	CA1282327C (da)
DE (2)	DE3689983T2 (da)
DK (2)	DK166478B1 (da)
ES (1)	ES2001993A6 (da)
FI (1)	FI86146C (da)
HK (1)	HK65393A (da)
IE (2)	IE66255B1 (da)
NO (1)	NO175763C (da)
SG (1)	SG64993G (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE8429928U1 (de) *	1984-10-11	1986-02-13	Sträter, Fritz, 5882 Meinerzhagen	Konzepthalter zur Anwendung an Schreib-, Zeichen-, Bildschirmarbeitsplätzen und dgl.
KR940000232B1 (ko) *	1986-01-17	1994-01-12	쥬우가이세이야꾸 가부시끼가이샤	니코란딜 제제의 안정화 방법
US5057317A (en) *	1987-03-24	1991-10-15	Chugai Seiyaku Kabushiki Kaisha	Slow-release pharmaceutical agent
CA1323833C (en) *	1987-04-28	1993-11-02	Yatindra M. Joshi	Pharmaceutical compositions in the form of beadlets and method
SE509029C2 (sv) *	1988-08-16	1998-11-30	Ss Pharmaceutical Co	Långtidsverkande diklofenak-natriumpreparat
IT1256022B (it) *	1992-06-08	1995-11-20		Preparazioni farmaceutiche stabili di nicorandil
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en)	1993-09-21	2001-02-06	Jagotec Ag	Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5602180A (en) *	1995-03-31	1997-02-11	World Health Group	Method of administering EDTA complexes
SG80553A1 (en) *	1995-07-20	2001-05-22	Tanabe Seiyaku Co	Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FR2742659B1 (fr) *	1995-12-22	1998-03-13	Pf Medicament	Procede de fabrication de minispheres matricielles a liberation prolongee
WO1999017751A1 (en) *	1997-10-03	1999-04-15	Smithkline Beecham Corporation	Controlled release solid dosage forms of lithium carbonate
JP5048177B2 (ja) *	1998-05-15	2012-10-17	中外製薬株式会社	放出制御製剤
CA2378265C (en) *	1999-08-09	2007-11-20	Dainippon Pharmaceutical Co., Ltd.	Solid preparations containing chitosan powder and process for producing the same
KR100463496B1 (ko)	1999-09-30	2005-01-06	펜웨스트 파머슈티칼즈 컴파니	고가용성 약물용 서방성 메트리스 시스템
JP4757995B2 (ja) *	1999-11-10	2011-08-24	大日本住友製薬株式会社	薬物放出製剤
DE10031043A1 (de) *	2000-06-26	2002-02-14	Bayer Ag	Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2002244247B2 (en)	2001-03-01	2007-12-13	Harbor Biosciences, Inc.	Use of certain steroids for treatment of blood cell deficiencies
US6720356B2 (en) *	2001-04-20	2004-04-13	Spencer Feldman	Magnesium di-potassium EDTA complex and method of administration
US6837696B2 (en) *	2001-09-28	2005-01-04	Mcneil-Ppc, Inc.	Apparatus for manufacturing dosage forms
US7323192B2 (en) *	2001-09-28	2008-01-29	Mcneil-Ppc, Inc.	Immediate release tablet
CA2447984A1 (en)	2001-09-28	2003-04-03	Mcneil-Ppc, Inc.	Dosage forms having an inner core and outer shell with different shapes
US7122143B2 (en)	2001-09-28	2006-10-17	Mcneil-Ppc, Inc.	Methods for manufacturing dosage forms
US7838026B2 (en)	2001-09-28	2010-11-23	Mcneil-Ppc, Inc.	Burst-release polymer composition and dosage forms comprising the same
US7094427B2 (en) *	2002-05-29	2006-08-22	Impax Laboratories, Inc.	Combination immediate release controlled release levodopa/carbidopa dosage forms
US20030224045A1 (en) *	2002-05-29	2003-12-04	Chien-Hsuan Han	Combination immediate release sustained release levodopa/carbidopa dosage forms
US20060013875A1 (en) *	2002-05-29	2006-01-19	Impax Laboratories, Inc.	Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) *	2002-05-29	2004-08-26	Chien-Hsuan Han	Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20090035260A1 (en) *	2002-07-29	2009-02-05	Therapicon Srl	Enhanced nasal composition of active peptide
US7807197B2 (en) *	2002-09-28	2010-10-05	Mcneil-Ppc, Inc.	Composite dosage forms having an inlaid portion
US20040228918A1 (en) *	2003-01-02	2004-11-18	Chih-Ming Chen	Granule modulating hydrogel system
ITMI20040235A1 (it) *	2004-02-13	2004-05-13	Therapicon Srl	Preparazione farmaceutica per il cavo orale
DE102004039196B4 (de)	2004-08-12	2008-07-31	Dr.Kamprad Kg	Neue Formulierung für L-Tryptophan
CA2582231A1 (en)	2004-09-29	2006-10-19	Hollis-Eden Pharmaceuticals, Inc.	Steroid analogs and uses
US8673352B2 (en) *	2005-04-15	2014-03-18	Mcneil-Ppc, Inc.	Modified release dosage form
WO2013153210A1 (en)	2012-04-13	2013-10-17	Nanoscape Ag	Sustained-release formulation
PL3054929T3 (pl)	2013-10-07	2021-05-31	Impax Laboratories, Llc	Mukoadhezyjne preparaty lewodopy i / lub estrów lewodopy o kontrolowanym uwalnianiu oraz ich zastosowania
US10987313B2 (en)	2013-10-07	2021-04-27	Impax Laboratories, Llc	Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
KR20230124622A (ko)	2020-12-22	2023-08-25	암닐 파마슈티컬스 엘엘씨	레보도파 투여 요법
US11986449B2 (en)	2020-12-22	2024-05-21	Amneal Pharmaceuticals Llc	Levodopa dosing regimen
CN117618376B (zh) *	2023-12-11	2024-08-13	江苏诺和必拓新药研发有限公司	一种尼可地尔膜控缓释片及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES300432A1 (es) *	1963-06-04	1964-11-16	Abbott Lab	Procedimiento para producir una composición analgésica
US3577491A (en) *	1968-01-02	1971-05-04	Miles Lab	Tableting
US3849558A (en) *	1969-06-03	1974-11-19	Sumitomo Chemical Co	Pharmaceutical compositions having controlled gastro-intestinal absorption
US3608063A (en) *	1969-08-15	1971-09-21	Gilbert S Banker	Molecular drug entrapment process and compositions
BE759520A (fr) *	1969-11-28	1971-04-30	Aspro Nicholas Ltd	Compositions d'aspirine
US3903255A (en) *	1971-05-17	1975-09-02	Rohm & Haas	Effervescent potassium chloride tablet
JPS5115094B2 (da) *	1972-11-01	1976-05-14
US3993999A (en) *	1975-05-16	1976-11-23	Texas Instruments Incorporated	Amplitude modulation scanning antenna system
US4021546A (en) *	1976-03-08	1977-05-03	Interx Research Corporation	Pro-drug forms of digoxin and method of preparing and using same
DE2656227C2 (de) *	1976-12-11	1985-07-04	Bayer Ag, 5090 Leverkusen	Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1576376A (en) *	1977-03-30	1980-10-08	Benzon As Alfred	Multiple-unit drug dose
US4180559A (en) *	1978-01-05	1979-12-25	Richardson-Merrell Inc.	Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DE2841170A1 (de) *	1978-09-21	1980-04-03	Pharmazeutische Praeparate Apo	Hypnotikum
US4342764A (en) *	1979-05-29	1982-08-03	Ciba-Geigy Corporation	Guanidine compounds, pharmaceutical compositions and use
US4406896A (en) *	1979-12-20	1983-09-27	Merck & Co., Inc.	Adjuvants for rectal delivery of drug substances
DE3011327A1 (de) *	1980-03-24	1981-10-01	Basf Ag, 6700 Ludwigshafen	1-aroyl-2-phenylamino-2-imidazoline, ihre herstellung und verwendung
ZA823333B (da) *	1981-04-24	1983-11-14
IT1198386B (it) *	1982-07-06	1988-12-21	Lepetit Spa	Un prodotto a rilascio protratto contenente il suloctidile
US4704284A (en) *	1982-08-12	1987-11-03	Pfizer Inc.	Long-acting matrix tablet formulations
US4503031A (en) *	1982-12-17	1985-03-05	Glassman Jacob A	Super-fast-starting-sustained release tablet
HU191542B (en) *	1983-04-08	1987-03-30	Boehringer Ingelheim Ltd	Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance
PH18946A (en) *	1983-04-21	1985-11-14	Elan Corp Plc	Controlled absorption pharmaceutical composition
DE3315797A1 (de) *	1983-04-30	1984-10-31	Beiersdorf Ag, 2000 Hamburg	Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4530920A (en) *	1983-11-07	1985-07-23	Syntex (U.S.A.) Inc.	Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
JPH0653658B2 (ja) *	1984-12-17	1994-07-20	中外製薬株式会社	安定な錠剤の製造法
FR2588559B1 (fr) *	1985-10-11	1988-03-11	Bp Chimie Sa	Procede de polymerisation ou de copolymerisation d'alpha-olefines en presence d'un systeme catalytique ziegler-natta ameliore

1986
- 1986-09-15 US US06/906,959 patent/US5188840A/en not_active Expired - Lifetime
- 1986-09-16 IE IE940953A patent/IE66255B1/en not_active IP Right Cessation
- 1986-09-16 AU AU62730/86A patent/AU587281B2/en not_active Expired
- 1986-09-16 IE IE246886A patent/IE81099B1/en not_active IP Right Cessation
- 1986-09-24 NO NO863796A patent/NO175763C/no not_active IP Right Cessation
- 1986-09-24 DK DK455286A patent/DK166478B1/da not_active IP Right Cessation
- 1986-09-25 EP EP90107877A patent/EP0386801B1/en not_active Expired - Lifetime
- 1986-09-25 ES ES8602189A patent/ES2001993A6/es not_active Expired
- 1986-09-25 DE DE3689983T patent/DE3689983T2/de not_active Expired - Lifetime
- 1986-09-25 EP EP86113193A patent/EP0218148B1/en not_active Expired - Lifetime
- 1986-09-25 DE DE8686113193T patent/DE3678661D1/de not_active Expired - Lifetime
- 1986-09-25 CA CA000519060A patent/CA1282327C/en not_active Expired - Lifetime
- 1986-09-25 AT AT90107877T patent/ATE108647T1/de not_active IP Right Cessation
- 1986-09-25 AT AT86113193T patent/ATE62408T1/de not_active IP Right Cessation
- 1986-09-25 JP JP61226468A patent/JPH0772142B2/ja not_active Expired - Fee Related
- 1986-09-26 FI FI863889A patent/FI86146C/fi not_active IP Right Cessation
- 1986-09-26 KR KR1019860008085A patent/KR950010145B1/ko not_active Expired - Fee Related
1992
- 1992-08-31 DK DK108192A patent/DK170110B1/da not_active IP Right Cessation
1993
- 1993-05-18 SG SG64993A patent/SG64993G/en unknown
- 1993-07-08 HK HK653/93A patent/HK65393A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU587281B2 (en)	1989-08-10
US5188840A (en)	1993-02-23
CA1282327C (en)	1991-04-02
IE940953L (en)	1987-03-26
IE862468L (en)	1987-03-26
DK108192A (da)	1992-08-31
ATE62408T1 (de)	1991-04-15
NO175763C (no)	1994-12-07
FI86146B (fi)	1992-04-15
EP0386801A2 (en)	1990-09-12
FI86146C (fi)	1992-07-27
IE66255B1 (en)	1995-12-27
NO863796D0 (no)	1986-09-24
DE3689983D1 (de)	1994-08-25
KR950010145B1 (ko)	1995-09-11
DK166478B1 (da)	1993-06-01
EP0386801B1 (en)	1994-07-20
ES2001993A6 (es)	1988-07-01
FI863889L (fi)	1987-03-27
NO175763B (no)	1994-08-29
DK455286D0 (da)	1986-09-24
JPH0772142B2 (ja)	1995-08-02
HK65393A (en)	1993-07-16
DK170110B1 (da)	1995-05-29
SG64993G (en)	1993-08-06
EP0218148B1 (en)	1991-04-10
DE3678661D1 (de)	1991-05-16
DK108192D0 (da)	1992-08-31
AU6273086A (en)	1987-04-02
ATE108647T1 (de)	1994-08-15
EP0386801A3 (en)	1990-11-07
KR870002838A (ko)	1987-04-13
FI863889A0 (fi)	1986-09-26
EP0218148A1 (en)	1987-04-15
JPS62149630A (ja)	1987-07-03
DE3689983T2 (de)	1995-02-23
IE81099B1 (en)	2000-03-08
NO863796L (no)	1987-03-27

Legal Events

Date	Code	Title	Description
2006-10-16	PUP	Patent expired

Publication	Publication Date	Title
DK455286D0 (da)	1986-09-24	Farmaceutisk middel med langsom frigaering og fremgangsmaade til dets fremstilling
DE3872739D1 (de)	1992-08-20	Arzneimittel mit langsamer freisetzung.
NO175240C (no)	1998-02-10	Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
DK582287A (da)	1987-11-05	Middel til fremstilling af faste doseringsformer med ensartet og forsinket frigoerelse
HU892559D0 (en)	1990-01-28	Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
RU93036959A (ru)	1996-05-20	Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NO883229D0 (no)	1988-07-20	Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
ES2009216A6 (es)	1989-09-16	Metodo de preparar un derivado de interleucina-lalfa.
YU161891A (sh)	1994-06-10	Postupak za dobijanje farmaceutski preparata oralnu primenu sa usporenim oslobadjanjem aktivne supstance bez rastvarača
IT1221079B (it)	1990-06-21	Derivati di anilina terapeuticamente attivi,procedimento per la loro preparazione e composizioni farmaceutiche che il contengono
CA2380757A1 (en)	2001-02-22	Pharmaceutical agent comprising a benzamide derivative as active ingredient
ES2174734A1 (es)	2002-11-01	Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
GEP20053581B (en)	2005-07-25	Pharmaceutical Composition and Method for Preparation Thereof
DK1144420T3 (da)	2004-04-13	Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
MY101266A (en)	1991-08-17	Pharmaceutical formulations
BR9710629A (pt)	1999-08-17	Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
HUT53121A (en)	1990-09-28	Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
MY102368A (en)	1992-06-17	Solid sustained-release composition
WO2001010415B1 (en)	2001-08-16	A binder for pharmaceutical compositions
ES8303915A1 (es)	1983-03-01	"procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
UA28457A (uk)	2000-10-16	Лікарський засіб "діпрацетам", що має знеболювальну та жарознижувальну дію та спосіб його одержання
ITMI922832A1 (it)	1994-06-11	DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.